Overview

Hyperpolarized Xenon MRI for Assessment of Pulmonary Function in Lung Resection

Status:
Completed
Trial end date:
2020-03-10
Target enrollment:
Participant gender:
Summary
This study compares the equivalence of hyperpolarized 129Xe MRI as compared to 133Xe scintigraphy for the evaluation of pulmonary function in patients being evaluated for lung resection.
Phase:
Phase 3
Details
Lead Sponsor:
Polarean Imaging Ltd.
Polarean, Inc.
Treatments:
Xenon